| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endra Life Sciences Inc. (NDRA) has 5 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. NDRA is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 136.6K | $773.1K | - | |
| CEO | 101.9K | $576.9K | - | |
| Dir | 65.7K | $371.9K | - | |
| Dir | 65.7K | $371.9K | - | |
| CFO | 33.5K | $189.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2019 | Wells David R. | Chief Financial Officer | Buy | 10,000 | $1.56 | $15,550.00 | +200.0% | |
| Jun 10, 2019 | Harsh Michael | Director | Buy | 500 | $1.14 | $570.00 | +5.3% | |
| Jun 7, 2019 | Harsh Michael | Director | Buy | 9,500 | $1.11 | $10,582.00 | +139.7% | |
| May 16, 2019 | Thornton Michael Milos45 | Chief Technology Officer | Buy | 30,000 | $1.13 | $33,900.00 | +33.4% | |
| Oct 24, 2018 | Longboard Capital Advisors, LLC | 10% Owner | Sell | 130,200 | $4.19 | $545,245.98 | -11.4% |